6-((6-(1-Methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)thio)quinoline

Name: 6-((6-(1-Methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)thio)quinoline | 1022150-57-7
Brand: US-CATO
SKU: S57C1021410_20_MG
Price: 19998.0 USD
Availability: InStock

Cat. No S57C1021410_20_MG

Vendor: US-CATO

Product Information

Product Name

6-((6-(1-Methyl-1H-pyrazol-4-yl)-1,2,4triazolo4,3-bpyridazin-3-yl)thio)quinoline

Brand Name

US-CATO

Product Number

C1021410

CAS

1022150-57-7

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

24779724

IUPAC Name

6-6-(1-methylpyrazol-4-yl)-1,2,4triazolo4,3-bpyridazin-3-ylsulfanylquinoline

InChI Key

BCZUAADEACICHN-UHFFFAOYSA-N

SMILES

CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=C(C=C4)N=CC=C5)C=C2

References Data Source From Pubchem

BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data

Publication Name: Nucleic Acids Research

Publication Date: 2024-11-22

DOI: 10.1093/nar/gkae1075

Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors

Publication Name: Bioorganic & Medicinal Chemistry

Publication Date: 2024-01-15

DOI: 10.1016/j.bmc.2023.117561

TTD: Therapeutic Target Database describing target druggability information

Publication Name: Nucleic Acids Research

Publication Date: 2023-09-15

DOI: 10.1093/nar/gkad751

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma

Publication Name: Cancer Letters

Publication Date: 2023-08-01

DOI: 10.1016/j.canlet.2023.216284

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Publication Name: Science Translational Medicine

Publication Date: 2023-06-21

DOI: 10.1126/scitranslmed.add7872